Option chain shows key data for Jupiter Neurosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Jupiter Neurosciences.

Jupiter Neurosciences (NASDAQ:JUNS) Stock, Option Chain

Jupiter Neurosciences

Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Biotech

News

Movers & Shakers

General

JUNS

How Jupiter Neuroscience&#39;s Two-Prong Approach Could Crack The Code On Biotech Success

Oracle

AAOI

CGTL

DIST

GNLN

HCTI

HSDT

HUSA

Hycroft Mining Holding Corporation - Class A Common Stock

HYMC

INTS

LIMN

ORCL

SLDP

TNXP

VTAK

ZCMD

Why Oracle Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Wall Street

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

DGNX

EVTL

ICON

NITO

VNCE

US Stocks Mixed; GE Aerospace Posts Upbeat Earnings

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences Inc

Press Releases

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson's Trial

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products

Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter

Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science

Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador

Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Alto Neuroscience

AN2 Therapeutics

Assertio Holdings

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Context Therapeutics

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Eyenovia

Grace Therapeutics

IGC Pharma

Iterum Therapeutics

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Pulmatrix

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Scilex Holding

SCYNEXIS

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

VYNE Therapeutics

Comments

Jupiter Neurosciences

Jupiter Neurosciences (JUNS) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell